Log in to save to my catalogue

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherap...

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherap...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7610680

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

About this item

Full title

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2021-04, Vol.40 (16), p.2923-2935

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The survival rate in lung cancer remains stubbornly low and there is an urgent need for the identification of new therapeutic targets. In the last decade, several members of the SWI/SNF chromatin remodeling complexes have been described altered in different tumor types. Nevertheless, the precise mechanisms of their impact on cancer progression, as...

Alternative Titles

Full title

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7610680

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7610680

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-021-01748-y

How to access this item